Inventor profile of:

Dwight D. Koeberl

City:

Durham, North Carolina

Country:

United States

Published Applications:

24

Last publication date:

2024-12-05

Top Assignees for applications by Dwight D. Koeberl

The entities that hold a legal rights for patent applications filed by inventor Koeberl Dwight D.:

Recent patent applications by Koeberl Dwight D.

Dwight D. Koeberl from Durham, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-12-05
US20240398729A1
Human necessities

Methods and Compositions for the Treatment of Cytoplasmic Glycogen Storage Disorders

#2 | 2023-09-14
US20230285329A1
Human necessities

Methods and compositions for the treatment of steatosis-associated disorders

#3 | 2023-09-14
US20230285328A1
Human necessities

Methods and Compositions for the Treatment of Steatosis-Associated Disorders

#4 | 2023-07-06
US20230210884A1
Human necessities

Immunomodulating Gene Therapy

#5 | 2022-12-08
US20220389399A1
Chemistry; metallurgy

ACID-ALPHA GLUCOSIDASE VARIANTS AND USES THEREOF

#6 | 2022-02-10
US20220040126A1
Human necessities

Methods and compositions for the treatment of cytoplasmic glycogen storage disorders

#7 | 2021-08-19
US20210251922A1
Human necessities

Methods and compositions for the treatment of steatosis-associated disorders

#8 | 2021-06-17
US20210177928A1
Human necessities

Method of reducing titers of antibodies specific for a therapeutic agent

#9 | 2019-12-26
US20190390184A1
Chemistry; metallurgy

Acid-alpha glucosidase variants and uses thereof

#10 | 2019-02-14
US20190046471A1
Human necessities

Methods and compositions for the treatment of steatosis-associated disorders

#11 | 2019-01-31
US20190030059A1
Human necessities

Immunomodulating gene therapy

#12 | 2018-12-27
US20180371440A1
Chemistry; metallurgy

CONSTRUCTS FOR EXPRESSING LYSOSOMAL POLYPEPTIDES

#13 | 2018-11-15
US20180326021A1
Human necessities

Methods and Compositions for the Treatment of Cytoplasmic Glycogen Storage Disorders

#14 | 2018-05-03
US20180117111A1
Human necessities

Method of reducing titers of antibodies specific for a therapeutic agent

#15 | 2017-06-15
US20170165316A1
Human necessities

Method of reducing titers of antibodies specific for a therapeutic agent

#16 | 2016-03-24
US20160082035A1
Human necessities

Immunomodulating gene therapy

#17 | 2015-02-05
US20150037329A1
Human necessities

Method of reducing titers of antibodies specific for a therapeutic agent

#18 | 2013-02-28
US20130052189A1
Human necessities

Method of reducing titers of antibodies specific for a therapeutic agent

#19 | 2012-11-01
US20120276072A1
Chemistry; metallurgy

Constructs for expressing lysosomal polypeptides

#20 | 2012-04-05
US20120082653A1
Human necessities

Methods of lysosomal storage disease therapy

#21 | 2011-12-01
US20110294193A1
Chemistry; metallurgy

VIRAL VECTORS AND METHODS FOR PRODUCING AND USING THE SAME

#22 | 2011-03-24
US20110070220A1
Human necessities

Immunomodulating gene therapy

#23 | 2005-10-06
US20050220766A1
Chemistry; metallurgy

Viral vectors and methods for producing and using the same

#24 | 2005-09-20
US10159946
-

Replicating adenovirus vectors

InventorID:

113564 ⎘